India CMO News

Recent industry report about India CMO company news, including latest market trends and industry updates in 2024. This sector news is compiled by Mordor Intelligence™ India CMO Market industry experts.

India CMO News

  • In June of 2022: Glenmark Pharmaceuticals introduced the cutting-edge fixed-dose combination (FDC) medication Indacaterol + Mometasone for patients with uncontrolled asthma in India. The business introduced this FDC under the name Indamet. Glenmark is the first business in India to commercialize the ground-breaking FDC of Indacaterol, a long-acting beta-agonist, and Mometasone Furoate, an inhaled corticosteroid that has been authorized by the Drug Controller General of India (DCGI),
  • In May 2022: Sun Pharma announced that one of its wholly-owned subsidiaries plans to launch a first-in-class oral drug, Bempedoic Acid, in India for reducing Low-Density Lipoprotein (LDL) cholesterol. The company will launch the drug under the brand name 'Brillo.'
  • In March 2022: The Mumbai-based pharmaceutical business Themis Medicare Ltd. announced that the Drug Controller General of India had approved their antiviral medication VIRALEX (DCGI). In mild to moderate Covid-19 sufferers, the medication aids in the early treatment of clinical symptoms, according to the findings of double-blind, randomized controlled trials (RCT).
download-icon Get full market coverage in this industry
Download PDF
  • July 2024: Debut, a leader in biotech beauty, unveiled BiotechXBeautyLabs. This innovative venture specializes in formulation development and contract manufacturing, focusing on next-generation, high-performing, and sustainable biotech products. BiotechXBeautyLabs partnered with global beauty brands through custom formulations and a curated selection of clinically-backed white-label offerings. This collaboration enables these brands to leverage biotechnology, ensuring market-leading performance, unique claims, and 95% bio-based formulations without incurring research costs.
  • April 2024: Lubrizol, a United States-based manufacturer of personal care ingredients, inked a memorandum of understanding with China's Proya Cosmetics, aiming to fast-track the creation of beauty products tailored to market demands. Capitalizing on a two-decade partnership, the two firms plan to harness their unique strengths to craft and promote beauty products that align with local market preferences and regulatory standards.
  • April 2024: Refresco, a prominent global provider of beverage solutions for major brands and retailers, finalized its acquisition of VBC Bottling Company, a premium beverage contract manufacturer based in the United States.
  • January 2024: Novelis inked a fresh deal with Ardagh Metal Packaging USA. The agreement entails Novelis supplying aluminum beverage packaging sheets to Ardagh's North American metal production sites. Notably, this marks Novelis's third significant contract in under seven months, solidifying its presence in North America's beverage packaging sector.
  • In June of 2022: Glenmark Pharmaceuticals introduced the cutting-edge fixed-dose combination (FDC) medication Indacaterol + Mometasone for patients with uncontrolled asthma in India. The business introduced this FDC under the name Indamet. Glenmark is the first business in India to commercialize the ground-breaking FDC of Indacaterol, a long-acting beta-agonist, and Mometasone Furoate, an inhaled corticosteroid that has been authorized by the Drug Controller General of India (DCGI),
  • In May 2022: Sun Pharma announced that one of its wholly-owned subsidiaries plans to launch a first-in-class oral drug, Bempedoic Acid, in India for reducing Low-Density Lipoprotein (LDL) cholesterol. The company will launch the drug under the brand name 'Brillo.'
  • In March 2022: The Mumbai-based pharmaceutical business Themis Medicare Ltd. announced that the Drug Controller General of India had approved their antiviral medication VIRALEX (DCGI). In mild to moderate Covid-19 sufferers, the medication aids in the early treatment of clinical symptoms, according to the findings of double-blind, randomized controlled trials (RCT).
  • April 2024: BloomPack entered a strategic partnership with Valmet, a prominent Finnish firm known for its expertise in process technologies, automation, and services, and Omya, a global leader in industrial mineral production and chemical product distribution. Through this partnership, BloomPack plans to spearhead innovations in paper production, notably crafting advanced coated white top liner grades that set new benchmarks in the industry.
  • October 2023: International technology group ANDRITZ announced that it would supply a complete fiber preparation line for a greenfield plant in the Toshka area in the south of Egypt. The pioneering and eco-friendly plant will produce high-density and medium-density fiberboard (HDF/MDF) from date palm fronds, a material normally considered farm waste.
  • July 2024: Debut, a leader in biotech beauty, unveiled BiotechXBeautyLabs. This innovative venture specializes in formulation development and contract manufacturing, focusing on next-generation, high-performing, and sustainable biotech products. BiotechXBeautyLabs partnered with global beauty brands through custom formulations and a curated selection of clinically-backed white-label offerings. This collaboration enables these brands to leverage biotechnology, ensuring market-leading performance, unique claims, and 95% bio-based formulations without incurring research costs.
  • April 2024: Lubrizol, a United States-based manufacturer of personal care ingredients, inked a memorandum of understanding with China's Proya Cosmetics, aiming to fast-track the creation of beauty products tailored to market demands. Capitalizing on a two-decade partnership, the two firms plan to harness their unique strengths to craft and promote beauty products that align with local market preferences and regulatory standards.
  • May 2024: Kraftpal reported that its Saudi Arabian mega factory project, aligned with the nation's Vision 2030 initiative, will be completed during the forecast period. Once operational, this facility would be a mega-plant wholly focused on producing corrugated pallets, with a staggering annual output capacity of 10 million pallets. Leveraging advanced technology, the factory would address the surging demand for innovative and eco-friendly pallet solutions and aim to reduce pallet costs and carbon emissions in global logistics. KraftPal's lightweight corrugated pallets present a greener substitute to traditional wooden pallets, further diminishing the carbon footprint.
  • January 2024: Saudi Arabia's sovereign wealth fund, the Public Investment Fund (PIF), finalized its investment in the Middle East Paper Company (MEPCO), headquartered in Jeddah. Through a capital increase and subscription to new shares, PIF has secured a 23.08% stake in MEPCO. This investment underscores the kingdom's and PIF's commitment to sustainability. It empowers MEPCO to enhance its production capacity, improve operational efficiency, and champion environmental sustainability with its recyclable offerings, including paper goods.
  • July 2024 - Gerresheimer announced the acquisition of Bormioli Pharma for EUR 800 (USD 893.57 million) million. Bormioli Pharma produces primary packaging made of glass and plastic and dispensing systems for the pharmaceutical industry
  • June 2024 - SCHOTT Hungary Kft. inaugurated production for pharmaceutical packaging products in Lukácsháza, Hungary. The facility will manufacture prefillable sterile glass syringes, doubling SCHOTT Pharma's production capacity for these products.
  • March 2024 - Schott Pharma announced plans to build a new production site for syringes in Wilson, North Carolina, USA. The facility will produce prefillable polymer syringes for mRNA drugs and prefillable glass syringes for treatments such as diabetes or obesity."
  • April 2024: Refresco, a prominent global provider of beverage solutions for major brands and retailers, finalized its acquisition of VBC Bottling Company, a premium beverage contract manufacturer based in the United States.
  • January 2024: Novelis inked a fresh deal with Ardagh Metal Packaging USA. The agreement entails Novelis supplying aluminum beverage packaging sheets to Ardagh's North American metal production sites. Notably, this marks Novelis's third significant contract in under seven months, solidifying its presence in North America's beverage packaging sector.
  • August 2024 - Mauser Packaging Solutions, one of the global leaders in industrial packaging and lifecycle solutions, has acquired a Pinetown-based business in Kwa-Zulu Natal, South Africa. This business specializes in manufacturing, selling, and supplying plastic drums, including significant rigid plastic variants. 
  • May 2024 - PT. SCHÜTZ Container Systems Indonesia inaugurated a new extrusion blow molding line at its Karawang facility. The company produces its PE bung barrel, the F1 220 litres, utilizing a sophisticated multi-layer process. This addition seamlessly integrates with Schütz'sestablished IBC product lineup. 
  • January 2024 - The Fedrigoni group, a speciality paper manufacturer for luxury packaging and other creative applications, self-adhesive labels and materials, and RFID and connectivity solutions acquired Arjowiggins China. The paper factory in Quzhou manufactures transparent papers sold under the Gateway and Sylvicta brands for applications such as industrial design and graphics for food, consumer electronics, or luxury packaging located in the Zhejiang Province.
  • December 2023 - The State Bank of India invested in the paper packaging industry by injecting INR 49.99 crore (USD 6.04 million) into Canpac Trends Private Limited, a company based in Ahmedabad specialising in paper-based packaging solutions. SBI invested in Canpac Trends with a view to capital appreciation, highlighting the growth and profitability potential of the paper packaging industry.

Contract Manufacturing In India Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)